Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care infrastructure in India ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...